bowel preparation before colonoscopy
Conditions
Interventions
1:290ug linalotide +1 bag of compound electrolyte powder
2:2 bag of compound electrolyte powder
3:1 bag of compound electrolyte powder
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Sign informed Consent form; (1) subjects agree with informed consent before screening, and to sign informed consent form voluntely, including accpeting screening procedure for diagonose; (2) Subject could have good communication with investigators and comply with protocol to conduct the study; 2. Patients aged 18-65 who underwent colonoscopy, regardless of gender;Correct use of intestinal cleansing drugs as required by the project; Case evaluation criteria: determine the mechanism and person, avoid selective data entry.
Exclusion criteria
Exclusion criteria: 1. previous history of acute myocardial infarction (within 6 months), with serious cardiac, hepatic and renal insufficiency or mental illness; 2. Patients who were taking aspirin, warfarin and other anticoagulant drugs, or having coagulation dysfunction; 3. Patients who were taking or/or had previously taken linalotide or were known to be allergic to linalotide, participants who were pregnant during the study period or who were planning to become pregnant; 4. Patients with inflammatory bowel disease, frequent diarrhea, severe gastroparesis and intestinal obstruction; 5. Patients who are participating in other clinical observation trials or participating in other clinical trials within 60 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of intestinal cleansing; | — |
Secondary
| Measure | Time frame |
|---|---|
| Polyp/adenoma detection number;side effect; | — |
Countries
China
Contacts
Public ContactHongwei Xu
Shandong Provincial Hospital
Outcome results
None listed